Valuation: PHARMAGEST INTER.

Market Cap 44Cr 50Cr 41Cr 38Cr 71Cr 4.79TCr 71Cr 499.2Cr 194.22Cr 2.44TCr 186.61Cr 182.58Cr 7.85TCr P/E 2026 *
9.94x
P/E 2027 * 8.95x
Enterprise Value 35Cr 39Cr 33Cr 30Cr 56Cr 3.8TCr 57Cr 395.97Cr 154.06Cr 1.94TCr 148.02Cr 144.82Cr 6.23TCr EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.2x
Free-Float
31.97%
Yield 2026 *
4.9%
Yield 2027 * 5.05%
Manager TitleAgeSince
Chief Executive Officer 57 22/04/2022
Director of Finance/CFO - 01/01/2023
Chief Tech/Sci/R&D Officer - 01/07/2018
Director TitleAgeSince
Chairman 61 25/06/2026
Director/Board Member 58 16/06/2011
Director/Board Member 57 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.86%+0.23%-23.58%+56.28% 21TCr
-2.12%+1.17%-6.45%+13.82% 19TCr
+3.73%+1.84%+63.11%+519.77% 12TCr
-0.04%+3.77%+40.39%+126.61% 12TCr
-1.72%+12.13%-21.17%-36.82% 12TCr
+1.90%+1.56%-27.14%-40.23% 7.81TCr
+0.32%+2.26%-26.77%-11.08% 5.82TCr
-2.08%+3.13%-34.45% - 4.94TCr
-0.15%+0.87%+15.33%+136.36% 4.48TCr
Average -0.10%+1.81%-2.30%+95.59% 11.07TCr
Weighted average by Cap. -0.26%+1.63%-0.70%+97.41%

Financials

2026 *2027 *
Net sales 25Cr 28Cr 24Cr 22Cr 41Cr 2.74TCr 41Cr 285.86Cr 111.22Cr 1.4TCr 106.86Cr 104.55Cr 4.5TCr 27Cr 30Cr 25Cr 23Cr 43Cr 2.9TCr 43Cr 302.74Cr 117.78Cr 1.48TCr 113.16Cr 110.72Cr 4.76TCr
Net income 4.41Cr 4.94Cr 4.11Cr 3.74Cr 7.04Cr 476.08Cr 7.09Cr 50Cr 19Cr 242.99Cr 19Cr 18Cr 781.04Cr 4.92Cr 5.52Cr 4.59Cr 4.18Cr 7.86Cr 531.68Cr 7.92Cr 55Cr 22Cr 271.36Cr 21Cr 20Cr 872.25Cr
Net Debt -9.17Cr -10Cr -8.54Cr -7.77Cr -15Cr -989.95Cr -15Cr -103.23Cr -40Cr -505.26Cr -39Cr -38Cr -1.62TCr -12Cr -14Cr -11Cr -10Cr -19Cr -1.3TCr -19Cr -135.8Cr -53Cr -664.68Cr -51Cr -50Cr -2.14TCr
Logo PHARMAGEST INTER.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (72.8%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.9%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (6.2%): digital communication, telemedicine and telehealth solutions; - software publishing for private practitioners and medical assistants (4.2%); - development of financing solutions for leased goods (0.9%; Nanceo). Net sales are distributed geographically as follows: France (87.5%), Italy (6.1%), Belgium (3%), Germany (2.5%), the United Kingdom (0.8%), and Ireland (0.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-